Natural control of HIV-1 replication and long-term nonprogression: Overlapping but distinct phenotypes

Journal of Infectious Diseases

Volumn 200, Issue 11, 2009, Pages 1636-1638

  Hunt, Peter W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

CD4 LYMPHOCYTE COUNT; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION CONTROL; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

EID: 72849149790     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/646610     Document Type: Note

References (21)

1. UNAIDS. Report on the global AIDS epidemic: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). 2008:1-36.
2. Buchbinder SP, Mehrotra DV, Duerr A, etal. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372:1881-1893
3. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl JMed 2000; 342: 921-929 (Pubitemid 30177052) (Pubitemid 30177052)
4. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007; 27:406-416
5. Blankson JN, Siliciano RF. Elite suppression of HIV-1 replication. Immunity 2008; 29:845-847
6. Madec Y, Boufassa F, Porter K, Meyer L. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS 2005; 19:2001-2007 (Pubitemid 41669025)
7. Greenough TC, Sullivan JL, Desrosiers RC. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med 1999; 340:236-237
8. + T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008; 197: 126-133.
9. + T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load. Clin Infect Dis 2008; 46:e78-82.
10. Grabar S, Selinger-Leneman H, Abgrall S, Pialoux G, Weiss L, Costagliola D. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV. AIDS 2009; 23:1163-1169
11. Okulicz JF, Marconi VC, Landrum μL, et al. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV Natural History Study. J Infect Dis 2009; 200:1713-1723 (in this issue).
12. Sajadi MM, Constantine NT, Mann DL, et al. Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors. J Acquir Immune Defic Syndr 2009; 50:403-408
13. Mellors JW, Margolick JB, Phair JP, et al. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA 2007; 297:2349-2350
14. Rodriguez B, Sethi AK, Cheruvu VK, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006; 296:1498-1506 (Pubitemid 44465514) (Pubitemid 44465514)
15. Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL. Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 2007; 117:3148-3154 (Pubitemid 350096967) (Pubitemid 350096967)
16. Silvestri G, Sodora DL, Koup RA, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003; 18:441-452 (Pubitemid 36351522) (Pubitemid 36351522)
17. Choudhary SK, Vrisekoop N, Jansen CA, et al. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 2007; 81:8838-8842 (Pubitemid 47242858) (Pubitemid 47242858)
18. Fellay J, Shianna KV, Ge D, et al. A wholegenome association study of major determinants for host control of HIV-1. Science 2007; 317:944-947 (Pubitemid 47301321) (Pubitemid 47301321)
19. Catano G, Kulkarni H, He W, et al. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLAB* 57 alleles. PLoS ONE 2008; 3:e3636.
20. Limou S, Le Clerc S, Coulonges C, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009; 199:419-426
21. van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, vant Wout AB, Schuitemaker H. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 2009; 23:19-28.